• 사상체질의학회지
• /
• 제20권2호
• /
• pp.129-134
• /
• 2008

1. Objectives The primary purpose of this case study is to report that a Soeumin Mang-yang Syndrome with redness of urine and urination difficulty was treated with 'Soeumin Seungyangikgibuja-tang(升陽益氣附子湯)(SIBT)' and then his symptoms, laboratory test(urine) and urine color improved. 2. Methods The patient has the symptoms including redness of urine, discomfort after urinating, general body sweating, constipation and thirst. We diagnosed him as Soeumin Mang-yang Syndrome. So we treated him with 'SIBT(升陽益氣附子湯)'. 3. Results and Conclusions After the constitutional treatment with SIBT(升陽益氣附子湯) on Soeumin Mang-yang Syndrome patient, his symptoms and laboratory test(urine) improved and urine color was clear. 'SBIT(升陽益氣附子湯)' is considered to be effective in Soeumin Mang-yang Syndrome. The change of urine color can be good evidence for the symtoms of Mang-yang Syndrome is improved.

• 대한화장품학회지
• /
• 제45권4호
• /
• pp.381-388
• /
• 2019

개인의 피부특성을 반영한 화장품에 대한 관심이 증가함에 따라 본 연구에서는 개인의 특성을 분류하기 위해 한의학 변증(辨證) 개념을 도입하여 피부특징 및 대상자 특성을 구분하고자 하였다. 변증 중 노화와 관련 있는 음허(陰虛)변증을 선정하였고, 건강한 40대와 50대 여성 218명을 음허변증으로 구분하여 피부특성과 설문응답패턴을 분석하였다. 피부특성은 Corneometer^®, Cutometer^®, Janus lll 측정기기를 활용하여 보습, 탄력, 모공, 주름, 색소침착, 피부색 및 피지 항목을 측정하였다. 설문은 음허설문지(yin-deficiency questionnaire, YDQ)와 피부상태설문지(modified skin type questionnaire)로 구성되어 있는데, 음허변증 여부에 따른 교차비(odds ratio) 분석과 유의한 피부특성 차이를 나타내는 설문 분석의 두 단계로 구분하여 분석하였다. 그 결과, 음허로 변증된 집단은 아닌 집단에 비해 보습과 탄력이 감소하고, 피부 붉기가 증가하는 유의한 차이를 확인하였으며, 얼굴 열감과 불면, 신체 수분 감소 항목에서 불편감을 호소하였고 피부 민감성 항목과 연관이 있음을 확인하였다. 본 연구 결과를 활용하여 음허변증과 관련된 설문 중 수분, 탄력, 붉기의 피부특성을 나타내는 설문을 바탕으로 해당 고객에게 제품을 추천할 수 있을 것으로 사료된다.

• Journal of Acupuncture Research
• /
• 제15권2호
• /
• pp.183-198
• /
• 1998

This study was done in order to present clinical trial method for safety of herb-acupuncture. The results were summerized as follow: In case of western medicine, clinical trial divides into four phase 1. Phase I: Investigate safety and drug movement for health people. 2. The first phase II: Investigate safety, effectiveness for the limited patient. The late phase II: Investigate propriety of an applicable disease, the way to use and dose. 3. Phase III: Through the comparative, public trial, investigate a final, applicable disease and side effect. 4. Phase IV: After NDA, investigate safety and effectiveness for the wide patients. In case of herb-acupuncture, we have to investigate the following for safety and effectiveness 1. Drug dose: Decide with 1/2 or 1/3 of oral dosage or a basis of animal's of maximum dosage or a ratio of man and animal. 2. Toxicity: Examine blood, urine, liver function, EKG, after herb-acupuncture during acertain period of time. 3. Regional response: Estimate response of swelling, redness, pruritus. etc 4. Treatment effectiveness: After exactly diagnosis, estimate effectiveness with a objective guide post.